S. Alhayli

发表

Allogeneic transplant compared to pediatric-inspired therapy for Philadelphia chromosome-negative adolescent and adult ALL in first complete remission

M. Aljurf, A. Kotb, N. Chaudhri, 2022, Bone Marrow Transplantation.

The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor‐risk cytogenetic abnormalities

M. Aljurf, N. Chaudhri, S. Hashmi, 2021, EJHaem.

Improved Outcome of a Pediatric-Inspired Protocol for High-Risk Adolescent and Young Adult Acute Lymphoblastic Leukemia Patients Using Peg-Asparaginase and Escalating Dose of Methotrexate: Tolerability and Outcome.

M. Aljurf, A. Kotb, N. Chaudhri, 2019, Clinical lymphoma, myeloma & leukemia.

Full dose Cyclophosphamide with the addition of Fludarabine for Matched Sibling transplants in Severe Aplastic Anemia: Flu/Cy conditioning for SAA.

M. Aljurf, A. Kotb, N. Chaudhri, 2021, Transplantation and cellular therapy.

Clinical course and outcomes of COVID‐19 in hematopoietic cell transplant patients, a regional report from the Middle East

M. Aljurf, R. Almaghrabi, M. Ayas, 2021, Bone Marrow Transplantation.

Improved survival in adolescents and young adults (AYA) patients aged 14–55 years with acute lymphoblastic leukemia using pediatric-inspired protocol – a retrospective analysis of a real-world experience in 79 of patients treated at a national tertiary care referral center

M. Aljurf, A. Kotb, N. Chaudhri, 2021, Leukemia research reports.

Evaluation of eltrombopag in thrombocytopenia post Hematopoietic cell transplantation.

M. Aljurf, S. Hashmi, N. Bakshi, 2020, Hematology/oncology and stem cell therapy.

Frontline-matched sibling donor transplant of aplastic anemia patients using primed versus steady-state bone marrow grafts

M. Aljurf, A. Kotb, N. Chaudhri, 2021, Annals of Hematology.

Outcome of hematopoietic stem cell transplantation (HCT) from HLA-matched related donor for Fanconi anemia (FA) in adolescents and adults: a retrospective study by Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT)

M. Aljurf, A. Ghavamzadeh, A. Bazarbachi, 2020, Bone Marrow Transplantation.

Outcomes of autologous stem cell transplantation for multiple myeloma in Saudi Arabia

M. Aljurf, N. Chaudhri, S. Hashmi, 2021, Annals of Saudi medicine.

Outcomes of allogeneic hematopoietic cell transplant for acute myeloid leukemia in adolescent patients

M. Aljurf, A. Kotb, N. Chaudhri, 2019, Bone Marrow Transplantation.

Refined hepatic grading system in chronic graft‐versus‐host disease improves prognostic risk stratification of long‐term outcomes

J. Lipton, A. Viswabandya, J. Mattsson, 2021, European journal of haematology.

Successful restoration of checkpoint inhibitors efficacy after allogeneic hematopoietic cell transplant for classic Hodgkin lymphoma patients.

M. Aljurf, N. Chaudhri, W. Rasheed, 2023, Seminars in oncology.

Data Unit, Translational Research, and Registries

M. Aljurf, F. Hussain, S. Alhayli, 2021, The Comprehensive Cancer Center.

“Incidence and significance of donor-specific antibodies in haploidentical stem cell transplantation”

M. Aljurf, N. Chaudhri, R. El Fakih, 2023, Bone Marrow Transplantation.

Improved survival of adolescents and young adults patients with T-cell acute lymphoblastic leukemia

M. Aljurf, A. Kotb, N. Chaudhri, 2023, International journal of hematologic oncology.

Myeloablative Haploidentical donor hematopoietic transplantation using post-transplant cyclophosphamide and antithymoglobulin.

N. Chaudhri, W. Rasheed, S. Ahmed, 2024, Transplantation and cellular therapy.

Incidence and risk factors for secondary graft failure in uniformly treated patients with severe aplastic anemia receiving fludarabine and cyclophosphamide for conditioning and matched sibling bone marrow graft as stem cell source.

M. Aljurf, N. Chaudhri, W. Rasheed, 2023, Cytotherapy.